©2022 Stanford Medicine
Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder
Not Recruiting
Trial ID: NCT00601354
Purpose
This study will evaluate the effectiveness of adding guided self-help group therapy to a
weight loss program in achieving weight loss and reducing binge eating in overweight binge
eaters.
Official Title
Comparing Orlistat/Alli to Orlistat/Alli Plus Guided Self-help Group Therapy in Overweight Binge Eaters
Stanford Investigator(s)
Debra Safer
Associate Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
Eligibility
Inclusion Criteria:
- Body mass index greater than 27
- Binge eating at least two times per week during the 6 months prior to study entry
Exclusion Criteria:
- Current psychosis
- Current suicidal ideations
- Pregnant
- Receiving concurrent psychotherapy
- Unstable on psychotropic medications for 3 months prior to study entry
Intervention(s):
behavioral: Emotion regulation group therapy
drug: Orlistat/alli program
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305